Response to Lim et al. re: Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19

摘要

The authors of the recent publication “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19” [ ] appreciate the questions that were submitted as a letter to the editor [ ] and the opportunity to address them to the best of our ability here.